We are excited to announce the completion of BioStat Solutions’ merger with the PharmaLex Group,
a leading provider of specialized services for the pharma, biotech and medical device industries worldwide. Becoming part of a larger organization with an excellent reputation and significant global footprint is an exciting step for BSSI and brings significant mutual benefits. Our services in statistical and data sciences are well aligned with PharmaLex’s existing statistical portfolio, including a strong global Regulatory Affairs, Pharmacovigilance and Quality Assurance portfolio. Please see full press release here.
What We Do
Founded in 2001, BioStat Solutions, LLC (BSSI) provides analytical expertise in the design, analysis, and interpretation of complex data to pharmaceutical and biotechnology companies. We proactively identify and provide analytical solutions to the data complexities inherent to the healthcare industry. The variety, volume and complexity of data are ever increasing. BSSI assists clients in navigating the landscape of high-dimensional data, including real world data, data derived from OMIC and electronic technologies. To meet these challenges, BSSI uses a collaborative approach bringing together statisticians, bioinformaticians, data scientists, statistical geneticists, epidemiologists, and programmers. As a team we work alongside our clients to support drug target identification and prioritization projects, biomarker development efforts, and complex drug, biologic and medical device studies.